Trupanion (NASDAQ:TRUP) Issues Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Trupanion (NASDAQ:TRUPGet Free Report) announced its quarterly earnings results on Wednesday. The financial services provider reported $0.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.06 by ($0.02), Zacks reports. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.11%. The company had revenue of $337.31 million during the quarter, compared to analyst estimates of $335.41 million.

Trupanion Stock Down 25.5 %

NASDAQ:TRUP opened at $35.40 on Friday. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of -153.91, a price-to-earnings-growth ratio of 8.29 and a beta of 1.60. Trupanion has a one year low of $19.69 and a one year high of $57.90. The stock has a 50-day simple moving average of $48.04 and a 200 day simple moving average of $47.89. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.66 and a current ratio of 1.66.

Insider Buying and Selling

In other Trupanion news, SVP Emily Dreyer sold 900 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $54.55, for a total value of $49,095.00. Following the transaction, the senior vice president now owns 23,808 shares of the company’s stock, valued at $1,298,726.40. This trade represents a 3.64 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Fawwad Qureshi sold 9,867 shares of the firm’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. Over the last three months, insiders sold 11,581 shares of company stock worth $615,159. Corporate insiders own 5.50% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on TRUP shares. Stifel Nicolaus lowered their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday. Northland Securities raised their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research note on Thursday, October 31st. Finally, Piper Sandler lowered their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Trupanion has an average rating of “Moderate Buy” and a consensus price target of $46.60.

Read Our Latest Analysis on TRUP

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

See Also

Earnings History for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.